Skip to main content
Year archive

Jagsonpal Pharmaceuticals Limited — 2025 filings

All 182 regulatory filings released by Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) in 2025, sourced directly from the official regulator.

182 Filings
2025 Period
2025 filings (182)
Filing Released Lang
Action(s) taken or orders passed
Regulatory Filings
2025-12-30 English
Pursuant to provisions of Regulation 30 of SEBI (LODR), 2015, we hereby submit the disclosure regarding the order received from authority.
Regulatory Filings
2025-12-30 English
Trading Window
Regulatory Filings
2025-12-26 English
Pursuant to SEBI (PIT) Regulations, 2015, the trading window for dealing in securities of Company shall remain closed from January 01, 2026 till 48 hours after declaration of unaudited ....
Regulatory Filings
2025-12-26 English
Copy of Newspaper Publication
Regulatory Filings
2025-12-05 English
Please find enclosed herewith copies of newspaper advertisement published on December 05, 2025 informing shareholders regarding opening of special window for Re-lodgement of transfer request ....
Regulatory Filings
2025-12-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-11-20 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that that the representatives of Jagsonpal Pharmaceuticals ....
Regulatory Filings
2025-11-20 English
Updates
Share Issue/Capital Change
2025-11-18 English
Allotment of 56,571 Equity Shares under the Jagsonpal Pharmaceuticals Limited employee stock option plan 2022.
Regulatory Filings
2025-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-11-07 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Please find enclosed transcript for the jagsonpal pharmaceuticals Limited Q2 FY 2026 earnings call held on November 04, 2025 ....
Regulatory Filings
2025-11-07 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-05 English
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, Please find enclosed copies of advertisement published on November 05, 2025, providing extracts of Unaudited Financial results ....
Regulatory Filings
2025-11-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-11-04 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Jagsonpal Pharmaceuticals ....
Regulatory Filings
2025-11-04 English
Press Release
Interim / Quarterly Report
2025-11-03 English
Investor Presentation
Interim / Quarterly Report
2025-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report
2025-11-03 English
Press Release and Investor Presentation on Un- Audited Financial Results for the quarter and half year ended September 30, 2025
Regulatory Filings
2025-11-03 English
Press Release and Investor Presentation on Un- Audited Financial Results for the quarter and half year ended September 30, 2025
Regulatory Filings
2025-11-03 English
Outcome of Board Meeting
Regulatory Filings
2025-11-03 English
Pursuant to regulation 30 & Regulation 33 of SEBI (LODR) Regulations, 2015 Please find enclosed the Unaudited Financial results along with its Limited review report of the Company for the ....
Regulatory Filings
2025-11-03 English
Pursuant to Regulation 30 & Regulation 33 of SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and ....
Regulatory Filings
2025-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-10-29 English
Pursuant to Regulation 30 of SEBI (LODR) 2015, we wish to inform you that company has scheduled a conference call with analysts/Investor on 04, November, 2025 to discuss its Q2 FY 26 Financial ....
Regulatory Filings
2025-10-29 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-27 English
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2025-10-27 English
Board Meeting — Financial Results
Regulatory Filings
2025-10-27 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-10-09 English
Compliance Certificate in terms of Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended September 30, 2025
Regulatory Filings
2025-10-09 English
Updates
Share Issue/Capital Change
2025-10-07 English
Allotment of 93,445 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employees Stock Option Plan 2022
Regulatory Filings
2025-10-07 English
General Updates
Board/Management Information
2025-10-07 English
Intimation under Regulation 30 (5) of SEBI (Listing obligations and disclosure Requirements) Regulations, 2015
Regulatory Filings
2025-10-07 English
Appointment
Board/Management Information
2025-10-07 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 relating to Appointment of Chief Financial Officer of the Company
Regulatory Filings
2025-10-07 English
Trading Window
Regulatory Filings
2025-09-26 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2025-09-26 English
Intimation for Closure of Trading window for declaration of Unaudited Financial results for the quarter and half year ended September 30, 2025
Regulatory Filings
2025-09-26 English
Voting Results of 46th Annual General Meeting in terms of Regulation 44 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 and Scrutinizer''s Report
Regulatory Filings
2025-09-26 English
Shareholders meeting
AGM Information
2025-09-24 English
Proceedings of 46th Annual general Meeting (AGM) of the Company and disclosure under SEBI (Listing Obligations and disclosure Requirements) Regulations, 2015
Regulatory Filings
2025-09-24 English
Copy of Newspaper Publication
Annual Report
2025-09-20 English
Newspaper Publication of Corrigendum to 46th Annual Report of the Company
Regulatory Filings
2025-09-20 English
Corrigendum to the Annual Report for the Financial Year 2024-25
Regulatory Filings
2025-09-19 English
Press Release
Board/Management Information
2025-09-04 English
Press Release on Appointment of Mr. Amrut Medhekar as Chief Operating Officer of the Company.
Regulatory Filings
2025-09-04 English
Appointment
Regulatory Filings
2025-09-04 English
Appointment of Mr. Amrut Medhekar as the Chief Operating Officer (COO) (Senior Managerial Personnel) of the Company
Regulatory Filings
2025-09-04 English
Copy of Newspaper Publication
AGM Information
2025-09-02 English
General Updates
Report Publication Announcement
2025-09-02 English
Letter to Shareholders whose E-mail ID has not been registered with the company for accessing Annual Report and Notice of 46th Annual General Meeting of the company in accordance with Regulation ....
Regulatory Filings
2025-09-02 English
Newspaper Publication of Notice of 46th Annual General Meeting and E- voting information
Regulatory Filings
2025-09-02 English
Business Responsibility and Sustainability Report of the Company for the Financial Year 2024-25
Regulatory Filings
2025-09-01 English
Shareholders meeting
Annual Report
2025-09-01 English
Notice of the 46th Annual General Meeting of the company to be held on Wednesday, September 24, 2025 at 3:30 P.M. (IST)
Regulatory Filings
2025-09-01 English
Notice of 46th Annual General Meeting and Annual Report for the FY 2024-25
Regulatory Filings
2025-09-01 English
Copy of Newspaper Publication
Legal Proceedings Report
2025-08-13 English
Newspaper Advertisement- 46th Annual General Meeting (AGM) of the company to be held through Video Conferencing(VC)/ Other Audio Visual Means (OAVM) on September 24, 2025
Regulatory Filings
2025-08-13 English
Updates
Share Issue/Capital Change
2025-08-08 English
Allotment of Equity Shares under the Jagsonpal Phamaceuticals Limited Employee Stock Option Plan 2022
Regulatory Filings
2025-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-07-31 English
Earnings call Transcript for Jagsonpal Pharmaceuticals Limited Q1FY 26 Earnings Conference call held on July 28, 2025 at 3:00 P.M.
Regulatory Filings
2025-07-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-07-28 English
Audio Recording of Jagsonpal Pharmaceuticals Limited Q1 FY26 Earnings Conference Call on July 28 ,2025 at 3:00 P.M
Regulatory Filings
2025-07-28 English
Copy of Newspaper Publication
Regulatory Filings
2025-07-28 English
Extracts of Unaudited Financial Results- copy of Newspaper Advertisement
Regulatory Filings
2025-07-28 English
Investor Presentation
Investor Presentation
2025-07-26 English
Revised Press release for Unaudited Financial Results for the quarter ended June 30, 2025
Regulatory Filings
2025-07-26 English
Revised Investors Presentation for financial Results for the quarter ended June 30, 2025
Regulatory Filings
2025-07-26 English
Press Release (Revised)
Investor Presentation
2025-07-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report
2025-07-26 English
Press Release
Interim / Quarterly Report
2025-07-26 English
Press Release for Unaudited Financial Results for the quarter ended June 30, 2025
Regulatory Filings
2025-07-26 English
Press Release for Unaudited Financial Results for the quarter ended June 30, 2025
Regulatory Filings
2025-07-26 English
Record Date
AGM Information
2025-07-26 English
The 46th Annual General Meeting of the company will be held on September 24, 2025. The company has fixed September 12, 2025 as a Record Date for determining eligibility of shareholders ....
Regulatory Filings
2025-07-26 English
Unaudited Financial results for the quarter ended June 30, 2025
Regulatory Filings
2025-07-26 English
Outcome of Board Meeting
Regulatory Filings
2025-07-26 English
Outcome of Board Meeting Held on July 26, 2025 along with the Unaudited Financial Results for the quarter ended June 30, 2025.
Regulatory Filings
2025-07-26 English
Updates
Share Issue/Capital Change
2025-07-24 English
Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
Regulatory Filings
2025-07-24 English
Updates
Capital/Financing Update
2025-07-24 English
Intimation for Grant of Employees Stock Options
Regulatory Filings
2025-07-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-07-23 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a ....
Regulatory Filings
2025-07-23 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-23 English
Board Meeting — Financial Results
Regulatory Filings
2025-07-23 English
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2025 ,inter alia, to consider and approve Un- Audited Financial ....
Regulatory Filings
2025-07-23 English
Cessation
Board/Management Information
2025-07-08 English
Cessation of Employment of Mr. Sachin Jain, Chief Financial Officer of the Company
Regulatory Filings
2025-07-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-07-07 English
Compliance Certificate under Reg 74(5) of SEBI (D&P) Reg, 2018 for the quarter ended on 30 June, 2025
Regulatory Filings
2025-07-07 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2025-07-03 English
Trading Window
Regulatory Filings
2025-06-26 English
Intimation for Closure of Trading Window
Regulatory Filings
2025-06-26 English
We wish to inform you that the Company will participate in Group Conference (In-Person) on 26 June, 2025
Regulatory Filings
2025-06-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-06-16 English
Updates
Share Issue/Capital Change
2025-06-11 English
Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employees Stock Options Plan, 2022
Regulatory Filings
2025-06-11 English
Address Change
Regulatory Filings
2025-06-02 English
Shifting of the Registered office of the company within the local limits of the city in which the registered office of the company is situated
Regulatory Filings
2025-06-02 English
Annual Secretarial Compliance Report for the Financial year ended March 31, 2025 under Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements)
Regulatory Filings
2025-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-05-13 English
Earnings Call Transcript for Jagsonpal Pharmaceuticals Limited Q4FY25 Earnings Conference Call held on May 7, 2025
Regulatory Filings
2025-05-13 English
Copy of Newspaper Publication
Regulatory Filings
2025-05-08 English
Extract of Audited Standalone Financial Results- Copy of Newspaper Advertisement
Regulatory Filings
2025-05-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-05-07 English
Audio Recording of Jagsonpal Pharmaceuticals Limited Q4 FY25 Earnings Conference Call on May 07, 2025 at 4:00 P.M.
Regulatory Filings
2025-05-07 English
Updates
Share Issue/Capital Change
2025-05-06 English
Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
Regulatory Filings
2025-05-06 English
Updates
Capital/Financing Update
2025-05-06 English
Intimation of Grant of Employees Stock Options
Regulatory Filings
2025-05-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report
2025-05-06 English
Investors Presentation for the quarter and year ended March 31, 2025
Regulatory Filings
2025-05-06 English
Press Release
Interim / Quarterly Report
2025-05-06 English
Please find enclosed press release and Investor Presentation for the quarter and year ended March 31, 2025.
Regulatory Filings
2025-05-06 English
Updates
Regulatory Filings
2025-05-06 English
Termination of Business Transfer Agreement- Disclosure under Regulation 30 of SEBI Listing Regulations
Regulatory Filings
2025-05-06 English
The board of directors at its meeting held today has recommended a dividend of Rs. 2.5/- (125%) per equity share of face value of Rs. 2/- for the financial year ended March 31, 2025
Regulatory Filings
2025-05-06 English
Updates
Notice of Dividend Amount
2025-05-06 English
Audited (Standalone) Financial Results for the year ended March 31, 2025
Regulatory Filings
2025-05-06 English
Dividend
Regulatory Filings
2025-05-06 English
Outcome of Board Meeting
Regulatory Filings
2025-05-06 English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2025-05-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-04-30 English
Intimation of Analysts/Investors Conference call on Wednesday May 07, 2025, to discuss Q4 FY 25 financial results.
Regulatory Filings
2025-04-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-04-29 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-04-29 English
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve Financial results ....
Regulatory Filings
2025-04-29 English
Clarification on Significant Increase in the Volume
Regulatory Filings
2025-04-28 English
Clarification on Significant increase in volume of security of the Company, Required by NSE
Regulatory Filings
2025-04-28 English
Spurt in Volume
Regulatory Filings
2025-04-28 English
Updates
Share Issue/Capital Change
2025-04-21 English
Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
Regulatory Filings
2025-04-21 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-04-08 English
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2025-04-08 English
Action(s) initiated or orders passed
Regulatory Filings
2025-04-02 English
Further to our disclosure dated December 16, 2023 regarding the receipt of Demand cum Show Cause Notice from the Office of the Principal Commissioner of Customs (the "Authority"), we wish ....
Regulatory Filings
2025-04-02 English
Trading Window
Regulatory Filings
2025-03-26 English
Intimation of Closure of Trading Window
Regulatory Filings
2025-03-26 English
Updates
Share Issue/Capital Change
2025-03-13 English
Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
Regulatory Filings
2025-03-13 English
Updates
Board/Management Information
2025-03-13 English
We wish to inform you that consequent to the appointment of Mr. Pratham Rawal as Company Secretary, the board of directors have approved changes in KMPs authorized for purpose of determining ....
Regulatory Filings
2025-03-13 English
Change in Company Secretary/Compliance Officer
Board/Management Information
2025-03-13 English
Appointment of Mr. Pratham Rawal as Company Secretary and Compliance Officer of the Company w.e.f. March 13, 2025
Regulatory Filings
2025-03-13 English
Please find enclosed herewith resignation submitted by Mr. Abhishek Joshi, as Company Secretary and Compliance Officer & Key Managerial Personnel of the Company to pursue opportunity near my hometown.
Regulatory Filings
2025-03-03 English
Change in Company Secretary/Compliance Officer
Board/Management Information
2025-03-03 English
Please find enlcosed herewith response to additional details required under SEBI Circular dated November 11, 2024 for corporate Announcement filed under Reg. 30 SEBI LODR Regulations 2015
Regulatory Filings
2025-02-27 English
General Updates
Capital/Financing Update
2025-02-21 English
In compliance with Regulation 30 read with Schedule III of the Listing Regulations read with SEBI Master Circular. We wish to inform you that Jagsonpal Pharmaceuticals Limited has signed ....
Regulatory Filings
2025-02-21 English
Action(s) taken or orders passed
Regulatory Filings
2025-02-21 English
With reference to the above we wish to inform you that Company had received the warning letter dated February 05, 2025 from USFDA regarding observations during the inspection of contract ....
Regulatory Filings
2025-02-21 English
General Updates
Share Issue/Capital Change
2025-02-17 English
Pursuant to SEBI (Listing Obligation and Disclosure Requirements) Reg. 2015, as amended, we are pleased to inform you that the Nomination and Remuneration Committee has issued and alloted ....
Regulatory Filings
2025-02-17 English
We wish to inform you that consequent to appointment of Mr. Sachin Jain as Chief Financial Officer of the Company. The Board has approved changes in KMPs authorised to determine materiality ....
Regulatory Filings
2025-02-05 English
Updates
Board/Management Information
2025-02-05 English
Please be informed that based on recommendation of Nomination and Remuneration Committee, Audit Committee and Board at their meeting held today has approved appointment of Mr. Sachin Jain ....
Regulatory Filings
2025-02-05 English
Appointment
Board/Management Information
2025-02-05 English
Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, please find enclosed transcript of earning call of Jagsonpal Pharmaceuticals Limited held on January 23, 2025 at 10:00 AM.
Regulatory Filings
2025-01-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-01-29 English
Please find enclosed herewith copies of advertisement published on January 24, 2025 in ''Business Standard'' (English) and ''Business Standard'' (Hindi) newspaper providing extracts of ....
Regulatory Filings
2025-01-24 English
Copy of Newspaper Publication
Regulatory Filings
2025-01-24 English
The audio recording of the Jagsonpal Pharmaceuticals Limited Q3FY25 Earnings Conference Call held on January 23, 2025 at 10:00 AM for discussion of Q3FY25 Financial Results is available ....
Regulatory Filings
2025-01-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-01-23 English
Please find enclosed herewith the integrated filing (financial) for the quarter and nine- months ended December 31, 2024
Regulatory Filings
2025-01-23 English
Integrated Filing- Financial
Interim / Quarterly Report
2025-01-23 English
Please find enclosed herewith a copy of the Press Release and Investor Presentation for the Unaudited Financial Results for the quarter and nine months ended December 31, 2024.
Regulatory Filings
2025-01-22 English
Press Release
Interim / Quarterly Report
2025-01-22 English
Please find enclosed the Unaudited Financial Results along with Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2024.
Regulatory Filings
2025-01-22 English
Please find enclosed the Unaudited Financial Results along with Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2024.
Regulatory Filings
2025-01-22 English
Financial Result Updates
Regulatory Filings
2025-01-22 English
Outcome of Board Meeting
Regulatory Filings
2025-01-22 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-01-15 English
Please find enclosed intimation for conference call scheduled with the Analysts/Investors on Thursday, January 23, 2025, to discuss Q3 FY25 financial results.
Regulatory Filings
2025-01-15 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 ,inter alia, to consider and approve inter-alia, the ....
Regulatory Filings
2025-01-15 English
Board Meeting — Financial Results
Regulatory Filings
2025-01-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-01-03 English
We are enclosing the copy of certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and Share Transfer Agent of the Company for quarter ended December 31, 2024.
Regulatory Filings
2025-01-03 English